Substituted N-aryl-6-pyrimidinones: a new class of potent, selective, and orally active p38 MAP kinase inhibitors.
暂无分享,去创建一个
Dean M. Messing | G. Anderson | J. Monahan | R. Devraj | Jian Zhang | L. Xing | S. Selness | B. Devadas | H. Shieh | L. D. Marrufo | H. Madsen | Jerry Z Yang | E. Webb | H. M. Morgan